HomeCompareDODBX vs JNJ

DODBX vs JNJ: Dividend Comparison 2026

DODBX yields 6.76% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DODBX wins by $11.2K in total portfolio value
10 years
DODBX
DODBX
● Live price
6.76%
Share price
$13.11
Annual div
$0.89
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.3K
Annual income
$1,038.78
Full DODBX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — DODBX vs JNJ

📍 DODBX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDODBXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DODBX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DODBX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DODBX
Annual income on $10K today (after 15% tax)
$574.56/yr
After 10yr DRIP, annual income (after tax)
$882.96/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, DODBX beats the other by $179.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DODBX + JNJ for your $10,000?

DODBX: 50%JNJ: 50%
100% JNJ50/50100% DODBX
Portfolio after 10yr
$25.6K
Annual income
$933.28/yr
Blended yield
3.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DODBX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DODBX buys
0
JNJ buys
0
No recent congressional trades found for DODBX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDODBXJNJ
Forward yield6.76%3.36%
Annual dividend / share$0.89$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.3K$20.0K
Annual income after 10y$1,038.78$827.78
Total dividends collected$8.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DODBX vs JNJ ($10,000, DRIP)

YearDODBX PortfolioDODBX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,376$675.96$10,676$355.77+$700.00DODBX
2$12,891$718.66$11,407$389.39+$1.5KDODBX
3$14,554$761.09$12,198$426.53+$2.4KDODBX
4$16,376$803.09$13,056$467.62+$3.3KDODBX
5$18,367$844.50$13,987$513.12+$4.4KDODBX
6$20,538$885.20$14,998$563.56+$5.5KDODBX
7$22,901$925.07$16,098$619.52+$6.8KDODBX
8$25,468$964.01$17,295$681.69+$8.2KDODBX
9$28,253$1,001.94$18,599$750.82+$9.7KDODBX
10$31,269$1,038.78$20,022$827.78+$11.2KDODBX

DODBX vs JNJ: Complete Analysis 2026

DODBXStock

The investment seeks regular income, conservation of principal, and an opportunity for long-term growth of principal and income. The fund invests in a diversified portfolio of equity securities and debt securities. Under normal circumstances no less than 25% and no more than 75% of the fund&#39;s total assets will be invested in equity securities. It may invest up to 20% of its total assets in U.S. dollar-denominated equity or debt securities of non-U.S. issuers traded in the United States that are not in the S&P 500 Index.

Full DODBX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this DODBX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DODBX vs SCHDDODBX vs JEPIDODBX vs ODODBX vs KODODBX vs MAINDODBX vs ABBVDODBX vs MRKDODBX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.